Ji (2020)
Prediction for Progression Risk in Patients with COVID-19 Pneumonia: the CALL Score
https://doi.org/10.1093/cid/ciaa414
https://academic.oup.com/cid/article/doi/10.1093/cid/ciaa414/5818317
Comorbidities
Any comorbidity (Present vs. Not present)
COVID-19 (severe/critical)
Hazard ratio: 3.900 (1.900-7.900) Adjusted model

China

Retrospective cohort study

Medical records

208

aimed to clarify the high-risk factors with multivariate analysis and establish a prediction of disease progression

Overall, 208 consecutive confirmed patients with COVID-19 presented to two centers were enrolled from January 20 through February 22, 2020, the follow-up period ended in March 18, 2020.

Total

25 Day


COVID-19 (severe/critical)

40

COVID-19 (progression): All the consecutive patients with COVID-19 admitted to Fuyang second people??s hospital or the fifth medical center of Chinese PLA general hospital between January 20 and February 22, 2020, were enrolled and their clinical data were retrospectively collected.


Comorbidities

Any comorbidity

Comorbidity status

Not present

Present


Hazard ratio

3.900 (1.900-7.900)

No

Yes

Yes

D-dimer, underlying comorbidity, older age, higher LDH and lower lymphocyte


Using the CALL score model, clinicians can improve the therapeutic effect and reduce the mortality of COVID-19 with more accurate and reasonable resolutions on medical resources.

Good

Yes